Jing Du
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Du has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Chunjie Xiao
School of Medicine, Yunnan University, Kunming 650091, China
12 shared publicationsHaoran Li
School of Medicine
9 shared publicationsHongkun Bao
School of Medicine, Yunnan University Kunming Yunnan P. R. China
9 shared publicationsYue Jia
Department of Gynecology
9 shared publicationsShaolei Luo
School of Medicine, Yunnan University, Kunming 650091, China
8 shared publicationsYangyang Hou
School of Medicine, Yunnan University Kunming Yunnan P. R. China
8 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Medicine Plus
Ketamine rewires depressive circuits via coordinated multi-cell signaling
- 1 November 2026
- Published by KEAI Publishing in Medicine Plus
Open AccessKetamine rewires depressive circuits via coordinated multi-cell signaling
- 27 February 2026
- Published by Elsevier in Neuroscience Letters
- Vol. 877, 138569
Proteomic profiling of the prefrontal cortex reveals Dysregulated Mitochondria-Metabolism-Synapse axis in a chronic Stress-Induced mouse model of depression
- 27 February 2026
- Published by Elsevier in Neuroscience Letters
- Vol. 877, 138569
Proteomic profiling of the prefrontal cortex reveals Dysregulated Mitochondria-Metabolism-Synapse axis in a chronic Stress-Induced mouse model of depression
- 6 March 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 852, 138184
1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice
- 6 March 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 852, 138184
1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice
- Open Access
- 28 December 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-19
The Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia
Demyelinating diseases such as multiple sclerosis (MS) are chronic inflammatory autoimmune diseases and involve demyelination and axonal degeneration. Microglia rapidly respond to changes in the environment by altering morphotype and function during the progressive disease stage. Although substantial progress has been made in the drug development for MS, treatment of the progressive forms of the disease remains unsatisfactory. There is great interest in identifying novel agents for treating MS. Lentinus edodes is a traditional food, which can improve physiological function. Lentinan (LNT), a type of polysaccharide extracted from mushroom Lentinus edodes, is an anti-inflammatory and immunomodulatory agent. Here, we studied the remyelination effects of LNT and its therapeutic target in regulating the functions of neuroinflammation. We found that LNT enhanced remyelination and rescued motor deficiency by regulating dectin-1 receptor to inhibit neuroinflammation and microglial cell transformation. LNT promoted the conversion of microglial cells from the M1 status induced by LPS to the M2 status, enhanced the anti-inflammatory markers IL-10 and BDNF, inhibited inflammatory markers TNF-α and IL-1β, and downregulated the microglia activation and oligodendrocyte and astrocyte proliferation by modulating dectin-1. If we injected the dectin-1-specific inhibitor laminarin (Lam), the remyelination effects induced by LNT were completely abolished. Thus, these results suggest that LNT is a novel and potential therapeutic agent that can rescue MS neuroimmune imbalance and remyelination through a dectin-1 receptor-dependent mechanism.
- 28 December 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-19
Open AccessThe Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia
Demyelinating diseases such as multiple sclerosis (MS) are chronic inflammatory autoimmune diseases and involve demyelination and axonal degeneration. Microglia rapidly respond to changes in the environment by altering morphotype and function during the progressive disease stage. Although substantial progress has been made in the drug development for MS, treatment of the progressive forms of the disease remains unsatisfactory. There is great interest in identifying novel agents for treating MS. Lentinus edodes is a traditional food, which can improve physiological function. Lentinan (LNT), a type of polysaccharide extracted from mushroom Lentinus edodes, is an anti-inflammatory and immunomodulatory agent. Here, we studied the remyelination effects of LNT and its therapeutic target in regulating the functions of neuroinflammation. We found that LNT enhanced remyelination and rescued motor deficiency by regulating dectin-1 receptor to inhibit neuroinflammation and microglial cell transformation. LNT promoted the conversion of microglial cells from the M1 status induced by LPS to the M2 status, enhanced the anti-inflammatory markers IL-10 and BDNF, inhibited inflammatory markers TNF-α and IL-1β, and downregulated the microglia activation and oligodendrocyte and astrocyte proliferation by modulating dectin-1. If we injected the dectin-1-specific inhibitor laminarin (Lam), the remyelination effects induced by LNT were completely abolished. Thus, these results suggest that LNT is a novel and potential therapeutic agent that can rescue MS neuroimmune imbalance and remyelination through a dectin-1 receptor-dependent mechanism.
- 1 June 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 188, 114561
Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity
- 1 June 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 188, 114561
Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity
- Open Access
- 5 April 2021
- Published by Springer Nature in Neurochemical Research
- Vol. 46 (7) , 1725-1736
Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor
Neuroinflammation plays an important role in the onset and progression of neurodegenerative diseases. Microglia-mediated neuroinflammation have been proved to be the main reason for causing the neurodegenerative diseases. Ganoderic acid A (GAA), isolated from Ganoderma lucidum, showed anti-inflammatory effect in metabolism diseases. However, little research has been focused on the effect of GAA in neuroinflammation and the related mechanism. In the present study, lipopolysaccharide(LPS)-stimulated BV2 microglial cells were used to evaluate the anti-inflammatory capacity of GAA. Our data showed that GAA significantly suppressed LPS-induced BV2 microglial cells proliferation and activation in vitro. More strikingly, GAA promoted the conversion of BV2 microglial cells from M1 status induced by LPS to M2 status. Furthermore, GAA inhibited the pro-inflammatory cytokines release and promoted neurotrophic factor BDNF expression in LPS-induced BV2 microglial cells. Finally, we found that the expression of farnesoid-X-receptor (FXR) was prominently downregulated in LPS-stimulated BV2 microglial cells, antagonism of FXR with z-gugglesterone and FXR siRNA can reverse the effect of GAA in LPS-induced BV2 microglial cells. Taking together, our findings demonstrate that GAA can significantly inhibit LPS-induced neuroinflammation in BV2 microglial cells via activating FXR receptor.
- 5 April 2021
- Published by Springer Nature in Neurochemical Research
- Vol. 46 (7) , 1725-1736
Open AccessGanoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor
Neuroinflammation plays an important role in the onset and progression of neurodegenerative diseases. Microglia-mediated neuroinflammation have been proved to be the main reason for causing the neurodegenerative diseases. Ganoderic acid A (GAA), isolated from Ganoderma lucidum, showed anti-inflammatory effect in metabolism diseases. However, little research has been focused on the effect of GAA in neuroinflammation and the related mechanism. In the present study, lipopolysaccharide(LPS)-stimulated BV2 microglial cells were used to evaluate the anti-inflammatory capacity of GAA. Our data showed that GAA significantly suppressed LPS-induced BV2 microglial cells proliferation and activation in vitro. More strikingly, GAA promoted the conversion of BV2 microglial cells from M1 status induced by LPS to M2 status. Furthermore, GAA inhibited the pro-inflammatory cytokines release and promoted neurotrophic factor BDNF expression in LPS-induced BV2 microglial cells. Finally, we found that the expression of farnesoid-X-receptor (FXR) was prominently downregulated in LPS-stimulated BV2 microglial cells, antagonism of FXR with z-gugglesterone and FXR siRNA can reverse the effect of GAA in LPS-induced BV2 microglial cells. Taking together, our findings demonstrate that GAA can significantly inhibit LPS-induced neuroinflammation in BV2 microglial cells via activating FXR receptor.
- 1 March 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 185, 114422
Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism
- 1 March 2021
- Published by Elsevier in Biochemical Pharmacology
- Vol. 185, 114422
Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism
- 7 October 2020
- Published by Wiley in Journal of Neurochemistry
- Vol. 158 (2) , 358-372
Bag‐1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience
Molecular abnormalities within the Glucocorticoid Receptor (GR) stress signaling pathway involved in dysfunction of mitochondria and confer vulnerability to stress‐related psychiatric disorders. Bcl‐2 associated athanogene (Bag‐1) is a target for the actions of mood stabilizers. Bag‐1 interacts with GR, thereby regulating glucocorticoid function. In this study, we investigate the potential role of Bag‐1 in regulating GR translocation into mitochondria. Corticosterone (CORT) treatment significantly enhanced Bag‐1/GR complex formation and GR mitochondrial translocation in cultured rat cortical neurons after treatment for 30 min and 24 hr. By contrast, after stimulation with CORT for 3 days, localization of the Bag‐1/GR complex and mitochondrial GR were reduced. Similar results were obtained in mice, in which administrated CORT in drinking water for 21 days significantly impaired the GR levels in the mitochondria, while Bag‐1 over‐expression rescued this reduction. Furthermore, chronic CORT exposure led to anhedonia‐like and depression‐like behaviors in the sucrose‐consumption test and forced swimming test, and these behaviors were rescued by Bag‐1 over‐expression. These results suggest that Bag‐1 mediates GR trafficking to mitochondria and regulates affective resilience in response to a CORT increase and provide potential insight into the mechanisms by which Bag‐1 and GR could contribute to the physiology and pathogenesis of psychiatric disorders in response to the change of stress hormone. image
- 7 October 2020
- Published by Wiley in Journal of Neurochemistry
- Vol. 158 (2) , 358-372
Bag‐1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience
Molecular abnormalities within the Glucocorticoid Receptor (GR) stress signaling pathway involved in dysfunction of mitochondria and confer vulnerability to stress‐related psychiatric disorders. Bcl‐2 associated athanogene (Bag‐1) is a target for the actions of mood stabilizers. Bag‐1 interacts with GR, thereby regulating glucocorticoid function. In this study, we investigate the potential role of Bag‐1 in regulating GR translocation into mitochondria. Corticosterone (CORT) treatment significantly enhanced Bag‐1/GR complex formation and GR mitochondrial translocation in cultured rat cortical neurons after treatment for 30 min and 24 hr. By contrast, after stimulation with CORT for 3 days, localization of the Bag‐1/GR complex and mitochondrial GR were reduced. Similar results were obtained in mice, in which administrated CORT in drinking water for 21 days significantly impaired the GR levels in the mitochondria, while Bag‐1 over‐expression rescued this reduction. Furthermore, chronic CORT exposure led to anhedonia‐like and depression‐like behaviors in the sucrose‐consumption test and forced swimming test, and these behaviors were rescued by Bag‐1 over‐expression. These results suggest that Bag‐1 mediates GR trafficking to mitochondria and regulates affective resilience in response to a CORT increase and provide potential insight into the mechanisms by which Bag‐1 and GR could contribute to the physiology and pathogenesis of psychiatric disorders in response to the change of stress hormone. image